Cover Image
市場調查報告書

酒精性肝炎:全球臨床實驗檢討 (2015年前半期)

Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016

出版商 GlobalData 商品編碼 324946
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
酒精性肝炎:全球臨床實驗檢討 (2015年前半期) Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016
出版日期: 2016年10月31日 內容資訊: 英文 64 Pages
簡介

本報告提供酒精性肝炎相關之臨床研究最新趨勢調查,提供您地區·進展·PHASE·募集情況別之實驗量,代表性贊助商,開發中的治療藥資訊,並彙整全球各國的主要企業·機關的進展狀況,及有潛力的藥劑比較等資訊。

目錄

  • 簡介
    • 酒精性肝炎
    • 報告指南
  • 各地區的臨床實驗數量
    • 各國臨床實驗數量和平均實驗人數
      • 亞太地區主要國家的臨床實驗數量
      • 歐洲主要5個國家的臨床實驗數量
      • 北美主要國家的臨床實驗數量
  • G7各國臨床實驗數量:消化器官系統臨床實驗中酒精性肝炎的比例
  • G7各國臨床實驗數量:Phase別
  • G7各國臨床實驗數量:各進展狀況
  • E7各國對臨床實驗數量:消化管臨床實驗中酒精性肝炎的比例
  • E7各國臨床實驗數量:Phase別
  • E7各國臨床實驗數量:各進展狀況
  • Phase別臨床實驗數量
    • 進行中的臨床實驗:Phase別
  • 各進展狀況臨床實驗數量
  • 臨床實驗的目標達成情形
  • 未完成的臨床實驗數量:酒精性肝炎的情況
  • 一定期間所採用的實驗對像
  • 贊助商類別的臨床實驗數量
  • 有潛力的贊助商
    • 酒精性肝炎治療藥臨床實驗的主要參與企業
  • 有潛力的藥劑
  • 最新臨床實驗新聞:酒精性肝炎相關
  • 臨床實驗簡介
    • 主要企業臨床實驗概要
      • Vital Therapies Inc.
      • Conatus Pharmaceuticals Inc.
      • Alfact Innovation
      • Zhejiang Hisun Pharmaceutical Co., Ltd.
      • PharmaKing Co., Ltd.
      • Generon (Shanghai)Corporation Ltd.
    • 主要的研究機關/政府機關/醫院臨床實驗概要
      • University Hospital, Lille
      • Erasme University Hospital
      • University of Texas Southwestern Medical Center at Dallas
      • Dayanand Medical College & Hospital
      • Southern California Institute for Research and Education
      • Postgraduate Institute of Medical Education and Research
      • Virginia Commonwealth University
      • Seoul National University Hospital
      • Loma Linda University
      • National Center for Complementary and Alternative Medicine
  • 5個有代表性的臨床實驗簡介
  • 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC3839CTIDB

GlobalData's clinical trial report, "Alcoholic Hepatitis Global Clinical Trials Review, H2, 2016" provides an overview of Alcoholic Hepatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Alcoholic Hepatitis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Clinical Trials by G7 Countries: Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials 13
  • Clinical Trials by Phase in G7 Countries 14
  • Clinical Trials in G7 Countries by Trial Status 15
  • Clinical Trials by E7 Countries: Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials 16
  • Clinical Trials by Phase in E7 Countries 17
  • Clinical Trials in E7 Countries by Trial Status 18
  • Clinical Trials by Phase 19
  • In Progress Trials by Phase 20
  • Clinical Trials by Trial Status 21
  • Clinical Trials by End Point Status 22
  • Subjects Recruited Over a Period of Time 23
  • Clinical Trials by Sponsor Type 24
  • Prominent Sponsors 25
  • Top Companies Participating in Alcoholic Hepatitis Therapeutics Clinical Trials 26
  • Prominent Drugs 27
  • Clinical Trial Profile Snapshots 28

Appendix 61

  • Abbreviations 61
  • Definitions 61
  • Research Methodology 62
  • Secondary Research 62
  • About GlobalData 63
  • Contact Us 63
  • Disclaimer 63
  • Source 64

List of Tables

  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Region, 2016* 6
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2016* 9
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10
  • Alcoholic Hepatitis Therapeutics Clinical Trials, North America, Top Countries, 2016* 11
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Phase, 2016* 19
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Alcoholic Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List of Figures

  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Region (%), 2016* 6
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2016* 9
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10
  • Alcoholic Hepatitis Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, G7 Countries (%), 2016* 13
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14
  • Alcoholic Hepatitis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15
  • Proportion of Alcoholic Hepatitis to Gastrointestinal Clinical Trials, E7 Countries (%), 2016* 16
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17
  • Alcoholic Hepatitis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20
  • Alcoholic Hepatitis Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23
  • Alcoholic Hepatitis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26
  • Alcoholic Hepatitis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27
  • GlobalData Methodology 62
Back to Top